http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1393729-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 1992-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4f126d42b7f9f34ba58d59c885fe409 |
| publicationDate | 2004-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1393729-A3 |
| titleOfInvention | Combination chemotherapy involving topotecan and a platinum coordination compound |
| abstract | The invention relates to a pharmaceutical composition comprising a compound of thencamptothecin analog class and a platinum coordination compound and a pharmaceuticallynacceptable carrier or diluent; a method of inhibiting the growth of tumor cells in a humannafflicted therewith which comprises administering to such human an effective tumor cellngrowth inhibiting amount of such pharmaceutical composition; and a method of inhibitingnthe growth of tumor cells in a human afflicted therewith which comprises administering tonsuch human an effective tumor cell growth inhibiting amount of the combination of ancompound of the camptothecin analog class and a platinum coordination compound. n The compound of the camptothecin analog class is preferably topotecan. n The platinum coordination compound can for example be diammine(1,1-cyclobutanedicarboxylato)platinum(II)n(Carboplatin) or cisplatin. |
| priorityDate | 1991-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.